
News
25 days ago•3 min read
The Hidden Cost of J&J's 'Onshoring' Deal: Why the Pharma Supply Chain Just Got More Fragile
J&J's MFN deal signals a major shift in US pharma manufacturing, but is this national security win actually a massive economic trap?
D
DailyWorld Editorial